We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $3.37B
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$128M
Cap. Flow
+$26.2M
Cap. Flow %
2.17%
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28

Top Buys

Rank Stock Value
1
TME icon
Tencent Music
TME
+$28.3M
2
LEGN icon
Legend Biotech
LEGN
+$20.2M
3
TCOM icon
Trip.com Group
TCOM
+$16M
4
STAA icon
STAAR Surgical
STAA
+$10.7M
5
ZLAB icon
Zai Lab
ZLAB
+$7.74M

Top Sells

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$21.9M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$10.8M
3
NIO icon
NIO
NIO
+$10.3M
4
LI icon
Li Auto
LI
+$8.53M
5
BZ icon
Kanzhun
BZ
+$8.18M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 36.91%
2 Technology 25.51%
3 Communication Services 14.94%
4 Healthcare 9.44%
5 Real Estate 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCID icon
326
Lucid Motors
LCID
$2.53B
$109K 0.01%
1,596
-93
-6% -$10.2K
SANA icon
327
Sana Biotechnology
SANA
$946M
$106K 0.01%
26,824
-2,671
-9% -$13.1K
LYEL icon
328
Lyell Immunopharma
LYEL
$316M
$105K 0.01%
1,509
+799
+113% +$79.4K
ROIV icon
329
Roivant Sciences
ROIV
$25.2B
$105K 0.01%
+13,110
New +$72.9K
ALEC icon
330
Alector
ALEC
$170M
$101K 0.01%
10,891
-1,975
-15% -$17.2K
MCRB icon
331
Seres Therapeutics
MCRB
$48.8M
$93K 0.01%
833
+129
+18% +$17.3K
ATRA icon
332
Atara Biotherapeutics
ATRA
$71.2M
$86K 0.01%
1,054
-413
-28% -$43K
CRBU icon
333
Caribou Biosciences
CRBU
$161M
$70K 0.01%
+11,090
New +$98.7K
ERAS icon
334
Erasca
ERAS
$6.64B
$64K 0.01%
+14,832
New +$101K
ADAG
335
Adagene
ADAG
$228M
– –
-10,310
Closed -$13K
AMT icon
336
American Tower
AMT
$77.4B
– –
-942
Closed -$202K
ARCT icon
337
Arcturus Therapeutics
ARCT
$163M
– –
-12,713
Closed -$188K
BIDU icon
338
Baidu
BIDU
$35.7B
– –
-2,166
Closed -$254K
CNC icon
339
Centene
CNC
$31.3B
– –
-2,578
Closed -$201K
EPAM icon
340
EPAM Systems
EPAM
$4.88B
– –
-573
Closed -$208K
EW icon
341
Edwards Lifesciences
EW
$47.4B
– –
-2,575
Closed -$213K
HCM icon
342
HUTCHMED
HCM
$1.91B
– –
-58,861
Closed -$522K
HRTX icon
343
Heron Therapeutics
HRTX
$88.2M
– –
-41,391
Closed -$175K
JKS
344
JinkoSolar
JKS
$791M
– –
-35,000
Closed -$1.94M
LGND icon
345
Ligand Pharmaceuticals
LGND
$6.03B
– –
-4,012
Closed -$216K
LI icon
346
Li Auto
LI
$13B
– –
-370,520
Closed -$8.53M
MDXG icon
347
MiMedx Group
MDXG
$640M
– –
-11,207
Closed -$32K
NKTX icon
348
Nkarta
NKTX
$167M
– –
-11,085
Closed -$146K
RGNX icon
349
Regenxbio
RGNX
$641M
– –
-8,055
Closed -$213K
STNG icon
350
Scorpio Tankers
STNG
$3.87B
– –
-6,508
Closed -$274K
11 12 13
14
15

Similar funds

VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
QCG
Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

E Fund Management's Q4 2022 Portfolio in Review

As of Q4 2022, E Fund Management held 362 positions worth $1.2B, up 12% from $1.07B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

E Fund Management's Q4 2022 filing shows 28 new, 88 increased, 207 reduced and 28 closed positions. Its largest new stake was Akero Therapeutics: 9,604 shares worth $526K. The largest sale was KE Holdings, an estimated $21.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 37% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

  • E Fund Management's largest Q4 2022 buy was Akero Therapeutics: 9,604 shares worth $526K.
  • E Fund Management added most to Tencent Music in Q4 2022, an estimated $28.3M increase.
  • E Fund Management's biggest Q4 2022 reduction was KE Holdings, cutting an estimated $21.9M.
  • E Fund Management fully exited Li Auto in Q4 2022, selling an estimated $8.53M.
  • E Fund Management's ten largest holdings make up 57% of its $1.2B portfolio in Q4 2022.
  • E Fund Management opened 28 new positions and closed 28 in Q4 2022.
  • E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.2B.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.